Carcinoma of Ureter
Also known as: Ureter Urothelial Carcinoma / Ureter Carcinoma / Urothelial carcinoma ureter / Ureter transitional cell cancer / Transitional cell carcinoma ureter / Transitional cell carcinoma of ureter (disorder) / Malignant epithelial neoplasm of ureter (disorder) / Transitional cell carcinoma of upper urinary tract (disorder) / Transitional cell cancer of the renal pelvis and ureter NOS / Renal pelvis and ureter transitional cell cancer NOS / Transitional cell cancer of the renal pelvis and ureter / Renal pelvis and ureteric cancer NOS transitional cell / Renal pelvis and ureteral cancer transitional cell NOS / Renal pelvis and ureteric cancer transitional cell NOS
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11714 | Durvalumab | 0 | Active Not Recruiting | 1 |
DB11771 | Tremelimumab | 0 | Active Not Recruiting | 1 |
DB08875 | Cabozantinib | 1 | Active Not Recruiting | 1 |
DB06186 | Ipilimumab | 1 | Active Not Recruiting | 1 |
DB00305 | Mitomycin | 1 | Not Yet Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB01248 | Docetaxel | 2 | Completed | 1 |
DB13007 | Enfortumab vedotin | 2 | Terminated | 1 |
DB08871 | Eribulin | 2 | Completed | 1 |
DB00441 | Gemcitabine | 2 | Completed | 1 |
DB14824 | Icrucumab | 2 | Completed | 1 |
DB09035 | Nivolumab | 2 | Terminated | 1 |
DB09037 | Pembrolizumab | 2 | Terminated | 1 |
DB05578 | Ramucirumab | 2 | Completed | 1 |
DB12332 | Rucaparib | 2 | Terminated | 1 |
DB15036 | Sitravatinib | 2 | Terminated | 1 |
DB00441 | Gemcitabine | 3 | Recruiting | 1 |
DB00305 | Mitomycin | Not Available | Available | 1 |
DB00305 | Mitomycin | Not Available | Recruiting | 1 |